Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 417
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Molecules ; 28(6)2023 Mar 14.
Article in English | MEDLINE | ID: mdl-36985619

ABSTRACT

In this study, the allelopathic properties of Medicago sativa L. (alfalfa) seedling exudates on the germination of seeds of various species were investigated. The compounds responsible for the allelopathic effects of alfalfa were identified and characterized by employing liquid chromatography ion mobility high-resolution mass spectrometry. Crude exudates inhibited the germination of seeds of all various plant species tested. Overall, nine compounds in alfalfa were identified and quantified. The most predominant compounds were a hyperoside representing a flavonoid glucoside, the non-proteinogenic amino acid canavanine, and two dipeptides, identified as H-Glu-Tyr-OH and H-Phe-Glu-OH. The latter corresponds to the first finding that dipeptides are exuded from alfalfa seedlings. In addition, the antibacterial and antibiofilm activities of alfalfa exudate and its identified compounds were elucidated. Both hyperoside and canavanine revealed the best antibacterial activity with minimum inhibitory concentration (MIC) values that ranged from 8 to 32 and 32 to 256 µg/mL, respectively. Regarding the antibiofilm action, hyperoside and canavanine caused a decline in the percentage of E. coli isolates that possessed a strong and moderate biofilm-forming potential from 68.42% to 21.05% and 31.58%, respectively. Studies on their inhibiting effects exhibit that these major substances are predominantly responsible for the allelopathic and antimicrobial effects of the crude exudates.


Subject(s)
Medicago sativa , Seedlings , Medicago sativa/chemistry , Escherichia coli , Canavanine/analysis , Canavanine/pharmacology , Germination , Exudates and Transudates , Seeds/chemistry
2.
Cell Mol Life Sci ; 78(6): 3021-3044, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33230565

ABSTRACT

Arginine deprivation therapy (ADT) is a new metabolic targeting approach with high therapeutic potential for various solid cancers. Combination of ADT with low doses of the natural arginine analog canavanine effectively sensitizes malignant cells to irradiation. However, the molecular mechanisms determining the sensitivity of intrinsically non-auxotrophic cancers to arginine deficiency are still poorly understood. We here show for the first time that arginine deficiency is accompanied by global metabolic changes and protein/membrane breakdown, and results in the induction of specific, more or less pronounced (severe vs. mild) ER stress responses in head and neck squamous cell carcinoma (HNSCC) cells that differ in their intrinsic ADT sensitivity. Combination of ADT with canavanine triggered catastrophic ER stress via the eIF2α-ATF4(GADD34)-CHOP pathway, thereby inducing apoptosis; the same signaling arm was irrelevant in ADT-related radiosensitization. The particular strong supra-additive effect of ADT, canavanine and irradiation in both intrinsically more and less sensitive cancer cells supports the rational of ER stress pathways as novel target for improving multi-modal metabolic anti-cancer therapy.


Subject(s)
Canavanine/pharmacology , Endoplasmic Reticulum Stress/drug effects , Radiation Tolerance/drug effects , X-Rays , Activating Transcription Factor 4/antagonists & inhibitors , Activating Transcription Factor 4/genetics , Activating Transcription Factor 4/metabolism , Apoptosis/drug effects , Arginine/deficiency , Arginine/metabolism , Cell Culture Techniques , Cell Line, Tumor , Cell Proliferation/drug effects , Culture Media/chemistry , Endoribonucleases/antagonists & inhibitors , Endoribonucleases/genetics , Endoribonucleases/metabolism , Eukaryotic Initiation Factor-2/genetics , Eukaryotic Initiation Factor-2/metabolism , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/pathology , Humans , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , RNA Interference , RNA, Small Interfering/metabolism , Signal Transduction/drug effects , Squamous Cell Carcinoma of Head and Neck/metabolism , Squamous Cell Carcinoma of Head and Neck/pathology , Transcription Factor CHOP/antagonists & inhibitors , Transcription Factor CHOP/genetics , Transcription Factor CHOP/metabolism
3.
Clin Exp Pharmacol Physiol ; 42(3): 263-8, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25482045

ABSTRACT

The aim of the present study was to identify the effect of canavanine on the imidazoline receptor because canavanine is a guanidinium derivative that has a similar structure to imidazoline receptor ligands. Transfected Chinese hamster ovary-K1 cells expressing imidazoline receptors (nischarin (NISCH)-CHO-K1 cells) were used to elucidate the direct effects of canavanine on imidazoline receptors. In addition, the imidazoline I3 receptor has been implicated in stimulation of insulin secretion from pancreatic ß-cells. Wistar rats were used to investigate the effects of canavanine (0.1, 1 and 2.5 mg/kg, i.v.) on insulin secretion. In addition the a specific I3 receptor antagonist KU14R (4 or 8 mg/kg, i.v.) was used to block I3 receptors. Canavanine decreased blood glucose by increasing plasma insulin in rats. In addition, canavanine increased calcium influx into NISCH-CHO-K1 cells in a manner similar to agmatine, the endogenous ligand of imidazoline receptors. Moreover, KU12R dose-dependently attenuated canavanine-induced insulin secretion in HIT-T15 pancreatic ß-cells and in the plasma of rats. The data suggest that canavanine is an agonist of I3 receptors both in vivo and in vitro. Thus, canavanine would be a useful tool in imidazoline receptor research.


Subject(s)
Canavanine/pharmacology , Imidazoline Receptors/metabolism , Insulin/metabolism , Animals , Blood Glucose/metabolism , CHO Cells , Calcium/metabolism , Cricetinae , Cricetulus , Insulin Secretion , Male , Rats , Rats, Wistar
4.
Clin Exp Pharmacol Physiol ; 42(10): 1045-50, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26192192

ABSTRACT

Canavanine is a guanidinium derivative that contains the basic structure of the ligand(s) of imidazoline receptor (I-R). Canavanine has been reported to activate the imidazoline I-3 receptor (I-3R) both in vivo and in vitro. Additionally, the activation of the imidazoline I-2B receptor (I-2BR) by guanidinium derivatives may increase glucose uptake. Therefore, the effect of canavanine on the I-2BR was investigated in the present study. Glucose uptake into cultured C2 C12 cells was determined using the radio-ligated tracer 2-[(14) C]-deoxy-glucose. The changes in 5' AMP-activated protein kinase (AMPK) expression were also identified using Western blotting analysis. The canavanine-induced glucose uptake was inhibited in a dose-dependent manner by BU224 (0.01-1 µmol/L), which is a specific I-2BR antagonist, in the C2 C12 cells. Additionally, the canavanine-stimulated AMPK phosphorylation and glucose transporter (GLUT4) expression were also sensitive to BU224 inhibition in the C2 C12 cells. Moreover, both canavanine-stimulated glucose uptake and AMPK phosphorylation were attenuated by high concentrations of amiloride (1-2 µmol/L), which is another established I-2BR inhibitor, in a dose-dependent manner in C2 C12 cells. Additionally, compound C abolished the canavanine-induced glucose uptake and AMPK phosphorylation at a concentration (0.1 µmol/L) sufficient to inhibit AMPK. In conclusion, these data demonstrated that canavanine has an ability to activate I-2BR through the AMPK pathway to increase glucose uptake, which indicates I-2BR as a new target for diabetic therapy.


Subject(s)
Canavanine/pharmacology , Glucose/metabolism , Imidazoline Receptors/metabolism , AMP-Activated Protein Kinases/metabolism , Animals , Biological Transport/drug effects , Cell Line , Gene Expression Regulation/drug effects , Glucose Transporter Type 4/metabolism , Mice , Phosphorylation/drug effects
5.
J Periodontal Res ; 49(6): 801-9, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24494651

ABSTRACT

BACKGROUND: The domesticated legume, Canavalia gladiata (commonly called the sword bean), is known to contain canavanine. The fruit is used in Chinese and Japanese herbal medicine for treating the discharge of pus, but its pharmacological mechanisms are still unclear. OBJECTIVES: This study examined the effect of sword bean extract (SBE) on (i) oral bacteria and human oral epithelial cells in vitro, and (ii) the initiation and progression of experimental Porphyromonas gingivalis-induced alveolar bone resorption in rats. MATERIAL AND METHODS: A high-performance liquid chromatography/ultraviolet method was applied to quantitate canavanine in SBE. By assessing oral bacterial growth, we estimated the minimum inhibitory concentration and minimum bactericidal concentration of SBE, canavanine, chlorhexidine gluconate (CHX) solution. The cytotoxicity of SBE, canavanine, CHX, leupeptin and cystatin for KB cells was determined using a trypan blue assay. The effects of SBE, canavanine, leupeptin and cystatin on Arg-gingipain (Rgp) and Lys-gingipain (Kgp) were evaluated by colorimetric assay using synthetic substrates. To examine its effects on P. gingivalis-associated periodontal tissue breakdown, SBE was orally administered to P. gingivalis-infected rats. RESULT: Sword bean extract contained 6.4% canavanine. SBE and canavanine inhibited the growth of P. gingivalis and Fusobacterium nucleatum. The cytotoxicity of SBE, canavanine and cystatin on KB cells was significantly lower than that of CHX. Inhibition of Rgp with SBE was comparable to that with leupeptin, a known Rgp inhibitor, and inhibition of Kgp with SBE was significantly higher than that with leupeptin at 500 µg/mL ( p < 0.05). P. gingivalis-induced alveolar bone resorption was significantly suppressed by administration of SBE, with bone levels remaining comparable to non-infected animals ( p < 0.05). CONCLUSION: The present study suggests that SBE might be effective against P. gingivalis-associated alveolar bone resorption.


Subject(s)
Alveolar Bone Loss/prevention & control , Bacteroidaceae Infections/microbiology , Canavalia , Phytotherapy/methods , Plant Extracts/therapeutic use , Porphyromonas gingivalis/drug effects , Adhesins, Bacterial/drug effects , Alveolar Bone Loss/microbiology , Animals , Canavalia/chemistry , Canavanine/analysis , Canavanine/pharmacology , Canavanine/toxicity , Chlorhexidine/analogs & derivatives , Chlorhexidine/pharmacology , Chlorhexidine/toxicity , Chromatography, High Pressure Liquid , Cystatins/pharmacology , Cystatins/toxicity , Cysteine Endopeptidases/drug effects , Disease Progression , Epithelial Cells/drug effects , Gingipain Cysteine Endopeptidases , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Humans , KB Cells , Leupeptins/pharmacology , Leupeptins/toxicity , Male , Microbial Sensitivity Tests , Mouth Mucosa/cytology , Mouth Mucosa/drug effects , Plant Extracts/analysis , Rats , Rats, Wistar , Specific Pathogen-Free Organisms
6.
Article in English | MEDLINE | ID: mdl-24211442

ABSTRACT

Sodium azide is a strong mutagen which has been successfully employed in mutation breeding of crop plants. In biological systems, it is metabolized to azidoalanine, but further bioactivation to a putative ultimate mutagen as well as the nature of the induced DNA modifications leading to mutations remain elusive. In this study, mutations induced in the CAN1 gene of yeast Saccharomyces cerevisiae by the representative mutagen 3-azido-1,2-propanediol (azidoglycerol, AZG) have been sequenced. Analysis of the forward mutation spectrum to canavanine resistance revealed that AZG induced nearly exclusively G:C to A:T transitions. AZG also induced reversions to tryptophan prototrophy by base-pair substitutions in a dose-dependent manner. This unusual mutational specificity may be shared by other organic azido compounds.


Subject(s)
Azides/pharmacology , Mutagenesis/drug effects , Mutation/drug effects , Propylene Glycols/pharmacology , Saccharomyces cerevisiae/genetics , Amino Acid Transport Systems, Basic/genetics , Canavanine/pharmacology , DNA Mutational Analysis , Dose-Response Relationship, Drug , Drug Resistance, Fungal/genetics , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae Proteins/genetics , Tryptophan/pharmacology
7.
Nucleic Acids Res ; 40(17): 8406-15, 2012 Sep 01.
Article in English | MEDLINE | ID: mdl-22743272

ABSTRACT

UV radiation induces two major types of DNA lesions, cyclobutane pyrimidine dimers (CPDs) and 6-4 pyrimidine-pyrimidine photoproducts, which are both primarily repaired by nucleotide excision repair (NER). Here, we investigated how chronic low-dose UV (CLUV)-induced mutagenesis occurs in rad14Δ NER-deficient yeast cells, which lack the yeast orthologue of human xeroderma pigmentosum A (XPA). The results show that rad14Δ cells have a marked increase in CLUV-induced mutations, most of which are C→T transitions in the template strand for transcription. Unexpectedly, many of the CLUV-induced C→T mutations in rad14Δ cells are dependent on translesion synthesis (TLS) DNA polymerase η, encoded by RAD30, despite its previously established role in error-free TLS. Furthermore, we demonstrate that deamination of cytosine-containing CPDs contributes to CLUV-induced mutagenesis. Taken together, these results uncover a novel role for Polη in the induction of C→T transitions through deamination of cytosine-containing CPDs in CLUV-exposed NER deficient cells. More generally, our data suggest that Polη can act as both an error-free and a mutagenic DNA polymerase, depending on whether the NER pathway is available to efficiently repair damaged templates.


Subject(s)
DNA Repair , DNA-Directed DNA Polymerase/physiology , Mutagenesis , Ultraviolet Rays , Canavanine/pharmacology , DNA Damage , DNA Repair Enzymes/genetics , DNA-Directed DNA Polymerase/metabolism , Deamination , Gene Deletion , Pyrimidine Dimers/metabolism , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/radiation effects , Saccharomyces cerevisiae Proteins/genetics
8.
J Neurosci ; 32(4): 1429-35, 2012 Jan 25.
Article in English | MEDLINE | ID: mdl-22279227

ABSTRACT

Insect survival depends on contact chemosensation to sense and avoid consuming plant-derived insecticides, such as L-canavanine. Members of a family of ∼60 gustatory receptors (GRs) comprise the main peripheral receptors responsible for taste sensation in Drosophila. However, the roles of most Drosophila GRs are unknown. In addition to GRs, a G protein-coupled receptor, DmXR, has been reported to be required for detecting L-canavanine. Here, we showed that GRs are essential for responding to L-canavanine and that flies missing DmXR displayed normal L-canavanine avoidance and L-canavanine-evoked action potentials. Mutations disrupting either Gr8a or Gr66a resulted in an inability to detect L-canavanine. We found that L-canavanine stimulated action potentials in S-type sensilla, which were where Gr8a and Gr66a were both expressed, but not in Gr66a-expressing sensilla that did not express Gr8a. L-canavanine-induced action potentials were also abolished in the Gr8a and Gr66a mutant animals. Gr8a was narrowly required for responding to L-canavanine, in contrast to Gr66a, which was broadly required for responding to other noxious tastants. Our data suggest that GR8a and GR66a are subunits of an L-canavanine receptor and that GR8a contributes to the specificity for L-canavanine.


Subject(s)
Avoidance Learning/physiology , Canavanine/pharmacology , Drosophila Proteins/physiology , Insecticides/pharmacology , Receptors, Cell Surface/physiology , Action Potentials/genetics , Action Potentials/physiology , Animals , Animals, Genetically Modified , Avoidance Learning/drug effects , Drosophila Proteins/genetics , Mutation , Protein Subunits/genetics , Protein Subunits/physiology , Receptors, Cell Surface/genetics
9.
Mol Genet Genomics ; 288(5-6): 285-95, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23640107

ABSTRACT

Schizosaccharomyces pombe and Saccharomyces cerevisiae are excellent model organisms to study lifespan. We conducted screening to identify novel genes that, when overexpressed, extended the chronological lifespan of fission yeast. We identified seven genes, among which we focused on SPBC16A3.08c. The gene product showed similarity to Ylr150w of S. cerevisiae, which has affinity for guanine-quadruplex nucleic acids (G4). The SPBC16A3.08c product associated with G4 in vitro and complemented the phenotype of an S. cerevisiae Ylr150w deletion mutant. From these results, we proposed that SPBC16A3.08c encoded for a functional homolog of Ylr150w, which we designated ortholog of G4-associated protein (oga1 (+)). oga1 (+) overexpression extended the chronological lifespan and also decreased mating efficiency and caused both high and low temperature-sensitive growth. Deleting oga1 (+) resulted in caffeine-sensitive and canavanine-resistant phenotypes. Based on these results, we discuss the function of Oga1 on the chronological lifespan of fission yeast.


Subject(s)
DNA-Binding Proteins/genetics , G-Quadruplexes , Schizosaccharomyces pombe Proteins/genetics , Schizosaccharomyces/physiology , Caffeine/pharmacology , Canavanine/pharmacology , Cloning, Molecular , DNA-Binding Proteins/metabolism , Drug Resistance, Fungal/genetics , Gene Deletion , Gene Expression Regulation, Fungal , Genetic Complementation Test , Protein Kinases/genetics , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics , Schizosaccharomyces/drug effects , Schizosaccharomyces pombe Proteins/metabolism
10.
PLoS One ; 18(1): e0271016, 2023.
Article in English | MEDLINE | ID: mdl-36626373

ABSTRACT

We constructed a panel of S. pombe strains expressing DNA polymerase ε variants associated with cancer, specifically POLES297F, POLEV411L, POLEL424V, POLES459F, and used these to compare mutation rates determined by canavanine resistance with other selective methods. Canavanine-resistance mutation rates are broadly similar to those seen with reversion of the ade-485 mutation to adenine prototrophy, but lower than 5-fluoroorotic acid (FOA)-resistance rates (inactivation of ura4+ or ura5+ genes). Inactivation of several genes has been associated with canavanine resistance in S. pombe but surprisingly whole genome sequencing showed that 8/8 spontaneous canavanine-resistant mutants have an R175C mutation in the any1/arn1 gene. This gene encodes an α-arrestin-like protein involved in mediating Pub1 ubiquitylation of target proteins, and the phenotypic resistance to canavanine by this single mutation is similar to that shown by the original "can1-1" strain, which also has the any1R175C mutation. Some of the spontaneous mutants have additional mutations in arginine transporters, suggesting that this may marginally increase resistance to canavanine. The any1R175C strain showed internalisation of the Cat1 arginine transporter as previously reported, explaining the canavanine-resistance phenotype.


Subject(s)
Schizosaccharomyces pombe Proteins , Schizosaccharomyces , Schizosaccharomyces/genetics , Schizosaccharomyces/metabolism , Canavanine/pharmacology , Canavanine/metabolism , Mutation Rate , Schizosaccharomyces pombe Proteins/metabolism , Mutation , Arginine/metabolism , Arrestins/metabolism
11.
Int J Cancer ; 130(9): 2164-75, 2012 May 01.
Article in English | MEDLINE | ID: mdl-21647872

ABSTRACT

Single amino acid arginine deprivation is a promising strategy in modern metabolic anticancer therapy. Its potency to inhibit tumor growth warrants the search for rational chemo- and radio-therapeutic approaches to be co-applied. In this report, we evaluated, for the first time, the efficacy of arginine deprivation as anticancer therapy in three-dimensional (3D) cultures of human tumor cells, and propose a new combinatorial metabolic-chemo-radio-treatment regime based on arginine starvation, low doses of arginine natural analog canavanine and irradiation. A sophisticated experimental setup was designed to evaluate the impact of arginine starvation on four human epithelial cancer cell lines in 2D monolayer and 3D spheroid culture. Radioresponse was assessed in colony formation assays and by monitoring spheroid regrowth probability following single dose irradiation using a standardized spheroid-based test platform. Surviving fraction at 2 Gy (SF(2Gy)) and spheroid control dose(50) (SCD(50) ) were calculated as analytical endpoints. Cancer cells in spheroids are much more resistant to arginine starvation than in 2D culture. Spheroid volume stagnated during arginine deprivation, but even after 10 days of starvation, 100% of the spheroids regrew. Combination treatment, however, was remarkably efficient. In particular, pretreatment of cancer cells with the arginine-degrading enzyme arginase combined with or without low concentration of canavanine substantially enhanced cell radioresponse reflected by a loss in spheroid regrowth probability and SCD(50) values reduced by a factor of 1.5-3. Our data strongly suggest that arginine withdrawal alone or in combination with canavanine is a promising antitumor strategy with potential to enhance cancer cure by irradiation.


Subject(s)
Arginine/metabolism , Canavanine/pharmacology , Cytoprotection/drug effects , Neoplasms, Glandular and Epithelial , Radiation Tolerance/drug effects , Apoptosis/drug effects , Arginine/genetics , Canavanine/metabolism , Cell Line, Tumor , Enzyme Inhibitors/therapeutic use , HCT116 Cells , HT29 Cells , Humans , Neoplasms, Glandular and Epithelial/drug therapy , Neoplasms, Glandular and Epithelial/metabolism , Neoplasms, Glandular and Epithelial/radiotherapy , Spheroids, Cellular/metabolism , Spheroids, Cellular/pathology
12.
PLoS Biol ; 7(6): e1000147, 2009 Jun 30.
Article in English | MEDLINE | ID: mdl-19564899

ABSTRACT

For all animals, the taste sense is crucial to detect and avoid ingesting toxic molecules. Many toxins are synthesized by plants as a defense mechanism against insect predation. One example of such a natural toxic molecule is L-canavanine, a nonprotein amino acid found in the seeds of many legumes. Whether and how insects are informed that some plants contain L-canavanine remains to be elucidated. In insects, the taste sense relies on gustatory receptors forming the gustatory receptor (Gr) family. Gr proteins display highly divergent sequences, suggesting that they could cover the entire range of tastants. However, one cannot exclude the possibility of evolutionarily independent taste receptors. Here, we show that L-canavanine is not only toxic, but is also a repellent for Drosophila. Using a pharmacogenetic approach, we find that flies sense food containing this poison by the DmX receptor. DmXR is an insect orphan G-protein-coupled receptor that has partially diverged in its ligand binding pocket from the metabotropic glutamate receptor family. Blockade of DmXR function with an antagonist lowers the repulsive effect of L-canavanine. In addition, disruption of the DmXR encoding gene, called mangetout (mtt), suppresses the L-canavanine repellent effect. To avoid the ingestion of L-canavanine, DmXR expression is required in bitter-sensitive gustatory receptor neurons, where it triggers the premature retraction of the proboscis, thus leading to the end of food searching. These findings show that the DmX receptor, which does not belong to the Gr family, fulfills a gustatory function necessary to avoid eating a natural toxin.


Subject(s)
Canavanine/pharmacology , Drosophila Proteins/physiology , Drosophila melanogaster/physiology , Insecticides/pharmacology , Plants/metabolism , Animals , Avoidance Learning/drug effects , Canavanine/metabolism , Cell Line , Chemoreceptor Cells/cytology , Chemoreceptor Cells/drug effects , Chemoreceptor Cells/metabolism , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Drosophila melanogaster/genetics , Drosophila melanogaster/metabolism , Feeding Behavior/drug effects , Gene Expression/drug effects , Gene Expression Profiling , Humans , Immunohistochemistry , In Situ Hybridization , Insecticides/metabolism , Mutation , RNA Interference , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Receptors, Cell Surface/physiology , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Receptors, G-Protein-Coupled/physiology , Reverse Transcriptase Polymerase Chain Reaction
13.
Mol Biol Rep ; 39(4): 3573-83, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21713403

ABSTRACT

Elevated levels of reactive oxygen species (ROS) can attack almost all cell components including genomic DNA to induce many types of DNA damage. In this study, we used Saccharomyces cerevisiae with various mutations in a biological network supposed to prevent deleterious effects of endogenous ROS to test the effect of such a network on yeast chronological aging. Our results showed that cells with defects in cellular antioxidation, DNA repair and DNA damage checkpoints displayed a mutation rate higher than that of wild-type strain. Moreover, the chronological life span of most mutants as determined by colony formation was found to be shorter than that of wild-type cells, especially for the mutants defective in DNA replication and DNA damage checkpoints, although the observed cell number was almost the same for wild-type and mutant strains. The mutants were finally found to be more sensitive to SDS and lysing enzyme treatment, and that the degree of sensitivity was correlated with their chronological life span.


Subject(s)
Cell Wall/metabolism , DNA Damage , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/growth & development , Canavanine/pharmacology , Cell Cycle Checkpoints/drug effects , Cell Proliferation/drug effects , Cell Wall/drug effects , Colony Count, Microbial , DNA Repair/drug effects , DNA Replication/drug effects , Drug Resistance/drug effects , Flow Cytometry , Gene Deletion , Genes, Fungal/genetics , Mutation Rate , Oxidation-Reduction/drug effects , Oxidative Stress/drug effects , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Time Factors
14.
J Pharm Pharm Sci ; 15(2): 221-33, 2012.
Article in English | MEDLINE | ID: mdl-22579002

ABSTRACT

PURPOSE: African traditional medicinal plants, such as Sutherlandia frutescens have the potential to interact pharmacokinetically with the protease inhibitor class of antiretrovirals, thereby impacting on their safety and efficacy. The effects of extracts and phytochemical components of Sutherlandia frutescens, on the in vitro absorption and metabolism of the protease inhibitor, atazanavir were thus investigated. METHODS: Aqueous and methanolic extracts of Sutherlandia frutescens were prepared by freeze-drying of hot water and methanol decoctions of Sutherlandia frutescens plant material respectively, whilst crude triterpenoid glycoside and flavonol glycoside fractions were isolated by solvent extraction and subsequent column chromatography. Atazanavir was quantitated in the absence or presence of these compounds as well as commercially available purported constituents of Sutherlandia frutescens, namely, L-canavanine, L-GABA and D-pinitol, after a one hour co-incubation in Caco-2 cell monolayers and human liver microsomes. RESULTS: The triterpenoid and flavonol glycoside fractions were found to be present in the aqueous and methanolic extracts of Sutherlandia frutescens and were shown to contain the sutherlandiosides and sutherlandins known to be present in Sutherlandia frutescens. The aqueous extract and D-pinitol significantly reduced atazanavir accumulation by Caco-2 cells, implying a decrease in atazanavir absorption, whilst the opposite was true for the triterpenoid glycoside fraction. Both the aqueous and methanolic extracts inhibited atazanavir metabolism in human liver microsomes, whilst enhanced atazanavir metabolism was exhibited by the triterpenoid glycoside fraction. CONCLUSIONS: The extracts and phytochemical components of Sutherlandia frutescens influenced the accumulation of atazanavir by Caco-2 cells and also affected ATV metabolism in human liver microsomes. These interactions may have important implications on the absorption and metabolism and thus the overall oral bioavailability of atazanavir.


Subject(s)
Fabaceae , HIV Protease Inhibitors/metabolism , Oligopeptides/metabolism , Plant Extracts/pharmacology , Pyridines/metabolism , Atazanavir Sulfate , Caco-2 Cells , Canavanine/pharmacology , Glycosides/pharmacology , Humans , Inositol/analogs & derivatives , Inositol/pharmacology , Medicine, African Traditional , Microsomes, Liver/drug effects , Microsomes, Liver/metabolism , gamma-Aminobutyric Acid/pharmacology
15.
Biosci Biotechnol Biochem ; 76(1): 60-6, 2012.
Article in English | MEDLINE | ID: mdl-22232249

ABSTRACT

Hygromycin B is an aminoglycoside antibiotic that inhibits protein synthesis in prokaryotes and eukaryotes. Twenty-four hygromycin B-resistants mutants were isolated from sake yeast, and were divided into three different degrees of strength according to hygromycin B resistance. Three of four hygromycin B strongly resistant mutants produced increased amounts of isoamyl acetate in sake brewing test, although isoamyl alcohol levels remained unchanged. Many hygromycin B-resistants mutants showed higher E/A ratios than K-701 in culture with koji extract medium. Strain HMR-18 produced the largest amount of isoamyl acetate, and its alcohol acetyltransferase (AATFase) activity was 1.3-fold that of K-701. DNA microarray analysis showed that many genes overexpressed in HMR-18 were involved in stress responses (heat shock, low pH, and so on) but HMR-18 showed thermo- and acid-sensitivity. It was strongly resistant to hygromycin B and another aminoglycoside antibiotic, G418.


Subject(s)
Alcoholic Beverages/microbiology , Drug Resistance, Fungal/genetics , Hygromycin B/pharmacology , Mutation , Pentanols/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Acetyltransferases/metabolism , Canavanine/pharmacology , Cell Proliferation/drug effects , Leucine/analogs & derivatives , Leucine/pharmacology , Oligonucleotide Array Sequence Analysis , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/physiology , Stress, Physiological
16.
Anticancer Drugs ; 22(2): 148-57, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20717004

ABSTRACT

Arginine deprivation achieved by means of recombinant arginine-degrading enzymes is currently being developed as a novel anticancer enzymotherapy. In this study, we showed that arginine deprivation in vitro profoundly and selectively sensitized human cancer cells of different organ origin to low doses of canavanine, an arginine analogue of plant origin. In sensitive cancer cells arginine starvation led to the activation of caspase-9, caspase-3 and caspase-7, cleavage of reparation enzyme, polyADP ribosyl polymerase, and DNA fragmentation, which are the typical hallmarks of intrinsic apoptosis realized by the mitochondrial pathway. Co-administration of canavanine significantly accelerated and enhanced apoptotic manifestations induced by arginine deprivation. The augmentation of canavanine toxicity for cancer cells was observed when either a formulated arginine-free medium or complete medium supplemented with bovine arginase preparation was used. Cycloheximide efficiently rescued malignant cells from canavanine-induced cytotoxicity under arginine deprivation, suggesting that it results mainly from canavanine incorporation into newly synthesized proteins. Cancer cells sensitive or resistant to arginine deprivation alone were not capable of restoring their proliferation after 24 h of combined treatment, whereas pseudonormal cells retained such ability. Our data suggest that the incorporation of canavanine into anticancer treatment schemes based on artificially created arginine starvation could be a novel strategy in tumor enzymochemotherapy.


Subject(s)
Apoptosis/drug effects , Arginine/deficiency , Canavanine/pharmacology , Neoplasms/therapy , Arginine/analogs & derivatives , Arginine/metabolism , Canavanine/pharmacokinetics , Cell Line , Cell Line, Tumor , Cell Proliferation/drug effects , Drug Synergism , Drug Therapy, Combination , HEK293 Cells , HeLa Cells , Hep G2 Cells , Humans , Neoplasms/drug therapy , Neoplasms/metabolism , Neoplasms/pathology , Protein Binding
17.
Nucleic Acids Res ; 37(8): 2549-59, 2009 May.
Article in English | MEDLINE | ID: mdl-19264809

ABSTRACT

7,8-Dihydro-8-oxoguanine (8-oxoG) is an abundant and mutagenic DNA lesion. In Saccharomyces cerevisiae, the 8-oxoG DNA N-glycosylase (Ogg1) acts as the primary defense against 8-oxoG. Here, we present evidence for cooperation between Rad18-Rad6-dependent monoubiquitylation of PCNA at K164, the damage-tolerant DNA polymerase eta and the mismatch repair system (MMR) to prevent 8-oxoG-induced mutagenesis. Preventing PCNA modification at lysine 164 (pol30-K164R) results in a dramatic increase in GC to TA mutations due to endogenous 8-oxoG in Ogg1-deficient cells. In contrast, deletion of RAD5 or SIZ1 has little effect implying that the modification of PCNA relevant for preventing 8-oxoG-induced mutagenesis is monoubiquitin as opposed to polyubiquitin or SUMO. We also report that the ubiquitin-binding domain (UBZ) of Pol eta is essential to prevent 8-oxoG-induced mutagenesis but only in conjunction with a functional PCNA-binding domain (PIP). We propose that PCNA is ubiquitylated during the repair synthesis reaction after the MMR-dependent excision of adenine incorporated opposite to 8-oxoG. Monoubiquitylation of PCNA would favor the recruitment of Pol eta thereby allowing error-free incorporation of dCMP opposite to 8-oxoG. This study suggests that Pol eta and the post-replication repair (PRR) machinery can also prevent mutagenesis at DNA lesions that do not stall replication forks.


Subject(s)
DNA-Directed DNA Polymerase/genetics , Guanine/analogs & derivatives , Mutagenesis , Proliferating Cell Nuclear Antigen/metabolism , Saccharomyces cerevisiae/genetics , Ubiquitination , Binding Sites , Canavanine/pharmacology , DNA Glycosylases/genetics , DNA Glycosylases/metabolism , DNA Repair , DNA-Directed DNA Polymerase/chemistry , DNA-Directed DNA Polymerase/metabolism , Gene Deletion , Guanine/metabolism , Mutation , Proliferating Cell Nuclear Antigen/chemistry , Protein Structure, Tertiary , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics , Ubiquitin/metabolism
18.
PLoS One ; 16(3): e0235303, 2021.
Article in English | MEDLINE | ID: mdl-33730086

ABSTRACT

Continuous culture systems allow for the controlled growth of microorganisms over a long period of time. Here, we develop a novel test for mutagenicity that involves growing yeast in continuous culture systems exposed to low levels of mutagen for a period of approximately 20 days. In contrast, most microorganism-based tests for mutagenicity expose the potential mutagen to the biological reporter at a high concentration of mutagen for a short period of time. Our test improves upon the sensitivity of the well-established Ames test by at least 20-fold for each of two mutagens that act by different mechanisms (the intercalator ethidium bromide and alkylating agent methyl methanesulfonate). To conduct the tests, cultures were grown in small, inexpensive continuous culture systems in media containing (potential) mutagen, and the resulting mutagenicity of the added compound was assessed via two methods: a canavanine-based plate assay and whole genome sequencing. In the canavanine-based plate assay, we were able to detect a clear relationship between the amount of mutagen and the number of canavanine-resistant mutant colonies over a period of one to three weeks of exposure. Whole genome sequencing of yeast grown in continuous culture systems exposed to methyl methanesulfonate demonstrated that quantification of mutations is possible by identifying the number of unique variants across each strain. However, this method had lower sensitivity than the plate-based assay and failed to distinguish the different concentrations of mutagen. In conclusion, we propose that yeast grown in continuous culture systems can provide an improved and more sensitive test for mutagenicity.


Subject(s)
Ethidium/pharmacology , Methyl Methanesulfonate/pharmacology , Saccharomyces cerevisiae/drug effects , Canavanine/pharmacology , Culture Media/chemistry , DNA, Fungal/chemistry , DNA, Fungal/metabolism , Mutagenicity Tests/instrumentation , Mutagenicity Tests/methods , Saccharomyces cerevisiae/genetics , Whole Genome Sequencing
19.
J Exp Med ; 141(2): 483-96, 1975 Feb 01.
Article in English | MEDLINE | ID: mdl-1089746

ABSTRACT

The multiplication of Toxoplasma gondii was quantitated in human monocytes in vitro by phase-contrast microscopy. Toxoplasma multiplication was identical in monocytes from subjects byt was significantly inhibited in cells from both sources if the monocytes were preincubated with immune lymphocytes and toxoplasma monocytes were preincubated with immune lymphocytes and toxoplasma antigen. Supernates prepared from toxoplasma-immune lymphocytes incubated with toxoplasma antigen were also effective in inducing in monocytes the capacity to inhibit toxoplasma multiplication. Supernative acitivty was evident after lymphocytes and antigen were incubated for as little as 15 min. The instruction of monocytes was also repid and reversible. Monocytes were fully induced to inhibit toxoplasma multiplication after a 2 h exposure to an active supernate, but they lost their inhibitory capacity on culture in vitro for 48 h in the absece of immune cells or their products. The lymphocytes particupating in the monocyte induction were identified as t cells. The in vitro stimulation of monocytes appeared to exhibit some specificity, since no inhibition of toxopreotein derivative and lymphocytes from tuberculin-positive subjects, concanavalin a-stimulated lymphocytes, or their supermates. Supernates which induced monocytes to inhibit toxoplasma multiplication did not influence parasite growth in HeLa cells.


Subject(s)
Immunity, Cellular , Monocytes/immunology , T-Lymphocytes/immunology , Toxoplasma/immunology , Adult , Antigens , B-Lymphocytes/immunology , Canavanine/pharmacology , Cells, Cultured , Female , HeLa Cells , Humans , Lymphocyte Activation , Male , Microscopy, Phase-Contrast , Time Factors , Tuberculin/pharmacology , Tuberculin Test
20.
J Exp Med ; 182(3): 677-88, 1995 Sep 01.
Article in English | MEDLINE | ID: mdl-7544394

ABSTRACT

Nitric oxide (NO), a highly diffusible cellular mediator involved in a wide range of biological effects, has been indicated as one of the cytotoxic agents released by leukocytes to counteract malaria infection. On the other hand, NO has been implicated as a mediator of the neuropathological symptoms of cerebral malaria. In such circumstances NO production has been thought to be induced in host tissues by host-derived cytokines. Here we provide evidence for the first time that human red blood cells infected by Plasmodium falciparum (IRBC) synthesize NO. The synthesis of NO (measured as citrulline and nitrate production) appeared to be very high in comparison with human endothelial cells; no citrulline and nitrate production was detectable in noninfected red blood cells. The NO synthase (NOS) activity was very high in the lysate of IRBC (while not measurable in that of normal red blood cells) and was inhibited in a dose-dependent way by three different NOS inhibitors (L-canavanine, NG-amino-L-arginine, and NG-nitro-L-arginine). NOS activity in P. falciparum IRBC is Ca++ independent, and the enzyme shows an apparent molecular mass < 100 kD, suggesting that the parasite expresses an isoform different from those found in mammalian cells. IRBC release a soluble factor able to induce NOS in human endothelial cells. Such NOS-inducing activity is not tissue specific, is time and dose dependent, requires de novo protein synthesis, and is probably associated with a thermolabile protein having a molecular mass > 100 kD. Our data suggest that an increased NO synthesis in P. falciparum malaria can be directly elicited by soluble factor(s) by the blood stages of the parasite, without necessarily requiring the intervention of host cytokines.


Subject(s)
Amino Acid Oxidoreductases/physiology , Erythrocytes/parasitology , Plasmodium falciparum/enzymology , Protozoan Proteins/physiology , Amino Acid Oxidoreductases/antagonists & inhibitors , Amino Acid Oxidoreductases/blood , Animals , Arginine/analogs & derivatives , Arginine/pharmacology , Biological Factors/metabolism , Biological Factors/pharmacology , Canavanine/pharmacology , Cell Adhesion , Cells, Cultured , Citrulline/biosynthesis , Culture Media, Conditioned/pharmacology , Cyclic GMP/metabolism , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Endothelium, Vascular/enzymology , Enzyme Induction , Host-Parasite Interactions , Humans , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Nitrates/metabolism , Nitric Oxide/physiology , Nitric Oxide Synthase , Nitrites/metabolism , Nitroarginine , Plasmodium/enzymology , Plasmodium/growth & development , Plasmodium falciparum/drug effects , Plasmodium falciparum/growth & development , Protozoan Proteins/antagonists & inhibitors , Protozoan Proteins/blood , Protozoan Proteins/pharmacology , Species Specificity , Umbilical Veins
SELECTION OF CITATIONS
SEARCH DETAIL